Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Ethyol available on Canadian market

July 26, 1996

TPO711: Thrombopoietin useful as bone marrow cell proliferation therapy

July 26, 1996

Anticancer oligonucleotides from Taiho

July 26, 1996

Human Genome Sciences' VIGF antagonists in pipeline

July 26, 1996

New formulation of CGP-41251

July 26, 1996

Tyrosine kinase inhibitors in Pharmacia & Upjohn's pipeline

July 26, 1996

Octapeptide neuromedin B antagonists described

July 26, 1996

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Aphton announces commencement of phase III trials for Gastrimmune

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...